SeLective blood-filter trial for acute kidney injury in ICU
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a special device that filters parts of the blood to calm inflammation in people with severe acute kidney injury in the ICU. It may help improve recovery and reduce complications by “deactivating” certain immune cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be in the ICU and receiving a kidney machine treatment called CKRT
- Have acute kidney injury stage 2 or worse when CKRT starts
- Be between 18 and 80 years old
- Have been on CKRT for at least 12 hours but not more than 48 hours before enrollment
- Have at least one other life-threatening problem besides kidney failure
- Have a blood inflammation marker (C-reactive protein) above 3.5 mg/dL
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how treating severe kidney injury in the ICU may affect patients’ brain and thinking function over time. It compares measurements of brain activity and function after starting kidney replacement therapy.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
This trial tests ways to protect the kidneys in intensive-care patients who have moderate or severe acute kidney injury. If you are on a ventilator or medications to support blood pressure, this study may offer extra kidney care to help prevent further damage.
This trial compares two different timeframes for changing filters during a critical kidney support treatment (CRRT) used when kidneys suddenly fail in hospitalized patients. The goal is to understand which filter-change schedule works better and reduces complications.
This study looks at an add-on blood-filter treatment used in the ICU to help remove harmful substances like waste products, inflammation signals, or toxins from the blood. Results may help doctors understand whether this approach improves care and how it should be used.
This study looks at how to safely remove excess fluid from patients in the ICU who have sudden kidney failure and are on a special blood-filtering machine (CRRT). Researchers want to understand which patients have trouble tolerating fluid removal and how to prevent complications.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.